Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Full-Life Technologies Achieves Regulatory Milestone with Nuclear Permit, Advancing Radioisotope Facility Construction 2024-03-26 08:00
Mom Favorite Brand Momcozy Showcases Cutting-Edge Products at Medtrade 2024 2024-03-25 23:00
Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million 2024-03-25 22:54
GenieMD Awarded Frost & Sullivan's 2024 Company of the Year Award for Pioneering Virtual Chronic Disease Management Solutions Through Its Unified Virtual Care Platform 2024-03-25 22:31
WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones 2024-03-25 21:39
GC Genome to Present New Data at AACR 2024 2024-03-25 21:00
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member 2024-03-25 20:00
ANNOUNCEMENT OF 2023 ANNUAL RESULTS OF TONG REN TANG TECHNOLOGIES 2024-03-25 12:47
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World 2024-03-25 10:00
Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider 2024-03-25 09:51
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB 2024-03-25 08:04
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results 2024-03-22 19:00
The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for Metastatic NSCLC were Published in Cell Reports Medicine 2024-03-22 18:42
Antengene Announces Full Year 2023 Financial Results, Highlights Clinical Progress Across First-in-Class, Best-in-Class Pipeline 2024-03-22 18:00
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability 2024-03-22 17:14
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001 2024-03-22 08:00
NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy 2024-03-22 08:00
OcuMension (01477.HK) Invests Over RMB 123.8 Million in Research, Technology and Self-development Progress in Tandem, Main Product Sales Show Comprehensive Growth 2024-03-21 22:44
100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Capsule (UTD2) for the Treatment of Gastric Cancer 2024-03-21 20:30
FDA Grants Orphan Drug Designation to Cevidoplenib for ITP 2024-03-21 20:00
1 12 13 14 15 16 892